biopharmaceutical

- Genexine to focus on global drug development and commercialization - Near term milestones should drive shareholder value - Renewed effort to…

– Preclinical data demonstrate effects of MALT1 inhibition on suppression of pro-inflammatory cell activation, attenuation of multiple…

Cerebras CS-2 accelerates artificial intelligence work while radically reducing power consumption Cerebras Systems, the pioneer in high…

Alvotech and Oaktree Acquisition Corp. II establish financing facilities to enhance the company’s capital position and to replace any redeemed…

Asahi Kasei Medical concluded an agreement on April 14, 2022 (JST) through a U.S. subsidiary to wholly acquire Bionova Scientific, LLC, a provider of…

– JIXING to lead development and commercialization of LNZ100 and LNZ101 in Greater China – – LENZ to receive up to $110 million in upfront and…

U.S. Food and Drug Administration (FDA) provides feedback necessary to proceed into a phase 2 proof of concept (PoC)/dose ranging study of…

Absci to present in-silico drug discovery technology at NVIDIA GTC Breakthrough ML achievements highlight the viability of the computational lead…

Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its…

NexImmune, Inc. and Zephyr AI (Zephyr) announced a strategic partnership focusing on the discovery and validation of novel targets for new…